It is well known that multidrug-resistance efflux pumps can confer antibiotic resistance on bacteria. Now, it is becoming evident that certain classes of these pumps also increase bacterial pathogenicity. Laura Piddock proposes that, owing to this dual function, such efflux pumps have greater clinical relevance than has previously been thought.
